久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實業有限公司Logo

熱門詞: 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥

當前位置: 首頁 > 所有品牌 > Molecular Insight
Molecular Insight
Molecular Insight Molecular Insight

美國Molecular Insight Pharmaceuticals?
Molecular Insight醫藥公司是一家突出的私營生物制藥公司,致力于專利技術的改良,以開發新型的分子成像藥物。這些產品通過在分子水平上使疾病進程更加清晰而提高疾病的診療水平。公司總部在美國馬薩諸塞州劍橋市,已建立強大的產品管線,主要集中在涉及心血管、感染、腫瘤及神經領域的發展中的主要成像市場。

Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery and development of therapeutic radiopharmaceuticals and targeted molecular imaging agents for use in oncology and cardiology.

Molecular Insight takes advantage of specific disease-related changes at the cellular level that occur in cancers in order to target the delivery of therapeutic radiopharmaceuticals to treat tumor cells that have spread throughout the body. The selective accumulation of radiotherapeutic compounds in cancers allows direct tumor killing while sparing normal tissues of serious toxicity. Targeted radiotherapy for widespread cancers brings a well understood and successful therapy (radiation) to the treatment of late-stage cancers. Since the ‘therapy’ is localized in the tumors and the mass of nonradioactive compound is very low, side effects may be less severe than conventional chemotherapy. Due to the exquisite sensitivity of radiopharmaceutical molecular imaging (nuclear medicine), it is possible to detect disease at the cellular level, before anatomical changes occur, which become more apparent in later stages of disease. Imaging the disease-related changes at the level of the cell enables early disease detection and a more sensitive means of monitoring disease progression and response to therapy compared with current imaging technologies.

Molecular Insight has five clinical-stage candidates in development. The Company’s oncology candidates include: Azedra? for treatment of pheochromocytoma and neuroblastoma, Onalta? for the treatment of metastatic carcinoid and pancreatic neuroendocrine tumors, Solazed?, which targets malignant metastatic melanoma, and Trofex? for the detection of metastatic prostate cancer. Zemiva?, the Company’s cardiology candidate, is being developed for the diagnosis of acute myocardial ischemia.

Molecular Insight is headquartered in Cambridge, Massachusetts. The Company’s Common Stock trades on the NASDAQ Global Market under the symbol “MIPI.”
?

關于我們客戶服務產品分類法律聲明
主站蜘蛛池模板: 国产在线视频网 | 美日韩中文字幕 | 免费视频一区 | 亚洲欧美国产精品专区久久 | 日本一区二区三区在线观看 | 日韩欧美高清在线 | 高清 国产 日韩 欧美 | 亚洲欧洲精品一区二区三区 | 国产精品久久久久久久久久久久 | 欧美福利专区 | 广东东莞一级毛片免费 | 亚洲原创区 | 最新亚洲精品 | 国产69精品久久久久777 | 精品视频在线观看一区二区三区 | 国产日韩在线播放 | 日韩 亚洲 制服 欧美 综合 | 一区二区三区免费在线 | 欧美国产日韩在线播放 | 一97日本道伊人久久综合影院 | 伊人精品国产 | 在线播放国产一区 | 日韩亚洲视频 | 91精品国产91久久久久久 | 国产毛片一区二区三区 | 亚洲欧美日韩中文字幕在线 | 999久久久免费精品国产牛牛 | 国产一区二区三区视频 | 激情综合久久 | 97久久精品一区二区三区 | 亚洲图片在线观看 | 国产亚洲欧美一区二区 | 午夜欧美在线 | 久久99免费| 青青热久久国产久精品秒播 | 欧美日韩国产va另类 | 一边摸一边叫床一边爽 | 在线观看免费国产 | 亚洲欧美国产精品专区久久 | 国产一区二区三区免费在线观看 | 亚洲精品国产自在久久出水 |